Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Journal of the American Society of Nephrology : CJASN|October 9, 2021
Timing of Kidney Clamping and Deceased Donor Kidney Transplant OutcomesSimon Ville, Marine Lorent, Clarisse Kerleau, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 17, 2020
Resurgence of BK virus following Covid-19 in kidney transplant recipientsChristophe Masset, Simon Ville, Franck Halary, et al.
Kidney International Reports|March 18, 2021
Spectrum of Kidney Involvement in Patients with Myelodysplastic SyndromesNora Schwotzer, François Provot, Simon Ville, et al.
Iscience|January 14, 2026
A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammationDebajyoti Sinha, Thomas Laurent, Alexis Broquet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantationElodie Bailly, Simon Ville, Gilles Blancho, et al.
BJU International|June 11, 2021
Kidney transplantation from expanded criteria donors: an increased risk of urinary complications - the UriNary Complications Of Renal Transplant (UNyCORT) studyBenoit Mesnard, Maxime Leroy, James Hunter, et al.
Kidney International Reports|November 24, 2025
Shiga Toxin-Producing <i>Escherichia coli-</i>Associated Hemolytic Uremic Syndrome in Adult Kidney Transplant RecipientsManal Mazloum, Pierre Trémolières, Nesrine Baili, et al.
Kidney International|March 2, 2024
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathiesValentin Maisons, Anna Duval, Laurent Mesnard, et al.
Blood|December 3, 2020
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter studyFadi Fakhouri, Marc Fila, Aurélie Hummel, et al.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressureAdrien Joseph, Martin Eloit, Elie Azoulay, et al.
Pageof 5